Similar Papers

Paper Title
Journal
Date
Author
A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma.
Angela Buonadonna ... Thomas Brodowicz
Anti-Cancer Drugs | VOL. 28
Angela Buonadonna, et. al.Angela Buonadonna ... Thomas Brodowicz
01 Nov 2017
An observational, multicenter, retrospective, Italian Sarcoma Group (ISG) study of trabectedin in patients with advanced soft tissue sarcoma (STS).
Emanuela Palmerini ...
Journal of Clinical Oncology | VOL. 36
Emanuela Palmerini, et. al.Emanuela Palmerini ...
20 May 2018
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
...
Cancer Treatment Reviews | VOL. 102
, et. al. ...
14 Nov 2021
Abstract 2699: ERCC5 (XPG) status and clinical activity of trabectedin in patients with advanced soft-tissue sarcoma
Antoine Italiano ... Armelle Laurand
Cancer Research | VOL. 70
Antoine Italiano, et. al.Antoine Italiano ... Armelle Laurand
15 Apr 2010
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Editorial Board
-
European Journal of Cancer | VOL. 216
--
01 Feb 2025
Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models
Bradley D Menz ... Ashley M Hopkins
European Journal of Cancer | VOL. -
Bradley D Menz, et. al.Bradley D Menz ... Ashley M Hopkins
01 Feb 2025
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial
Guilhem Roubaud ... Karim Fizazi
European Journal of Cancer | VOL. -
Guilhem Roubaud, et. al.Guilhem Roubaud ... Karim Fizazi
01 Feb 2025
Optimal timing for Initiating First-Line Palliative Systemic Therapy in Asymptomatic Metastatic Esophagogastric Cancer: Insights from a European Delphi study
Denice Kamp ... Nadia Haj Mohammad
European Journal of Cancer | VOL. -
Denice Kamp, et. al.Denice Kamp ... Nadia Haj Mohammad
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.